Eli Lilly CEO weighs in on drug costs and health reform
June 15, 2017 at 15:09 PM EDT
Ricks advocated for faster FDA approval on generic drugs and "innovative breakthroughs."
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|